Teva finds regulatory VP at FDA gate

Generics-maker Teva Pharmaceutical has hired Gary Buehler, FDA's former head of generic drugs and outgoing deputy director, Office of Pharmaceutical Science. Buehler is set to retire from the FDA at the end of this week. He'll join Teva as VP for regulatory strategic operations. The drugmaker no doubt hopes to tap Buehler's insider insights for generics and biosimilars. Article

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.